Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Kuala Lumpur, Malaysia
SEC filing record 1 source field available
Fiscal year end
31 December
BioNexus Gene Lab Corp has filed 141 SEC EDGAR filings since 29 Jan 2019

SEC filing history

Showing 26-50 of 141 matching filings.

Per page
25
Current page
2
NT 10-K File 001-41750

NT 10-K

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 001-41750

DEFR 14A

Filing date
28 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41750

DEF 14A

Filing date
27 Feb 2025
Reporting date
19 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-41750

PRE 14A

Filing date
10 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-41750

NT 10-Q

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41750

DEF 14A

Filing date
16 Sep 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-41750

PRE 14A

Filing date
06 Sep 2024
Reporting date
06 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .